Orbit Genomics, Inc. — Form D/A
Orbit Genomics, Inc. of BOULDER, CO, a company, filed a Form D amendment with the SEC on 2025-07-28. The offering totals $2.0M, of which $780K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-07-28
- Form: D/A
- Accession: 0002058369-25-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $780K
- Remaining: $1.2M
- Minimum investment: $5K
- Investors: 15
- Date of first sale: 2024-07-29
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-541191
Issuer
- Name: Orbit Genomics, Inc.
- CIK: 0002058369
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 4665 NAUTILUS CT S, BOULDER, CO, 80301
- Phone: 720-515-0395
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Harold (Skip) N Garner | Director | Boulder, CO |
| Oerum N Mikael | Director | Boulder, CO |
| Julie N Silber | Director | Minneapolis, MN |
| Elizabeth (Dede) N Willis | Director | Boulder, CO |
| Harold (Skip) N Garner | Executive Officer | Boulder, CO |
| Elizabeth (Dede) N Willis | Executive Officer | Boulder, CO |
| Randy N Berholtz | Executive Officer | Boulder, CO |
Other filings by this issuer (1)
More